1
|
Hosh M, Antar S, Nazzal A, Warda M,
Gibreel A and Refky B: Uterine sarcoma: Analysis of 13,089 cases
based on surveillance, epidemiology and end results database. Int J
Gynecol Cancer. 26:1098–1104. 2016.PubMed/NCBI View Article : Google Scholar
|
2
|
Brooks SE, Zhan M, Cote T and Baquet CR:
Surveillance, epidemiology, and end results analysis of 2677 cases
of uterine sarcoma 1989-1999. Gynecol Oncol. 93:204–208.
2004.PubMed/NCBI View Article : Google Scholar
|
3
|
Amant F, Coosemans A, Debiec-Rychter M,
Timmerman D and Vergote I: Clinical management of uterine sarcomas.
Lancet Oncol. 10:1188–1198. 2009.PubMed/NCBI View Article : Google Scholar
|
4
|
Thiel FC and Halmen S: Low-grade
endometrial stromal sarcoma-a review. Oncol Res Treat. 41:687–692.
2018.PubMed/NCBI View Article : Google Scholar
|
5
|
Chang KL, Crabtree GS, Lim-Tan SK, Kempson
RL and Hendrickson MR: Primary uterine endometrial stromal
neoplasms. A clinicopathologic study of 117 cases. Am J Surg
Pathol. 14:415–438. 1990.PubMed/NCBI View Article : Google Scholar
|
6
|
Hoang L, Chiang S and Lee CH: Endometrial
stromal sarcomas and related neoplasms: New developments and
diagnostic considerations. Pathology. 50:162–177. 2018.PubMed/NCBI View Article : Google Scholar
|
7
|
Leath CA III, Huh WK, Hyde J Jr, Cohn DE,
Resnick KE, Taylor NP, Powell MA, Mutch DG, Bradley WH, Geller MA,
et al: A multi-institutional review of outcomes of endometrial
stromal sarcoma. Gynecol Oncol. 105:630–634. 2007.PubMed/NCBI View Article : Google Scholar
|
8
|
Riopel J, Plante M, Renaud MC, Roy M and
Têtu B: Lymph node metastasis in low-grade endometrial stromal
sarcoma. Gynecol Oncol. 96:402–406. 2005.PubMed/NCBI View Article : Google Scholar
|
9
|
Xie W, Cao D, Yang J, Jiang X, Shen K, Pan
L, Huang H, Lang J, You Y and Chen J: Fertility-sparing surgery for
patients with low-grade endometrial stromal sarcoma. Oncotarget.
8:10602–10608. 2017.PubMed/NCBI View Article : Google Scholar
|
10
|
Laurelli G, Falcone F, Scaffa C, Messalli
EM, Del Giudice M, Losito S and Greggi S: Fertility-sparing
management of low-grade endometrial stromal sarcoma: Analysis of an
institutional series and review of the literature. Eur J Obstet
Gynecol Reprod Biol. 195:61–66. 2015.PubMed/NCBI View Article : Google Scholar
|
11
|
Jin Y, Li Y, Deng CY, Tian QJ, Chen H and
Pan LY: Fertility-sparing treatment of low-grade endometrial
stromal sarcoma. Int J Clin Exp Med. 8:5818–5821. 2015.PubMed/NCBI
|
12
|
Bai H, Yang J, Cao D, Huang H, Xiang Y, Wu
M, Cui Q, Chen J, Lang J and Shen K: Ovary and uterus-sparing
procedures for low-grade endometrial stromal sarcoma: A
retrospective study of 153 cases. Gynecol Oncol. 132:654–660.
2014.PubMed/NCBI View Article : Google Scholar
|
13
|
Amant F, De Knijf A, Van Calster B, Leunen
K, Neven P, Berteloot P, Vergote I, Van Huffel S and Moerman P:
Clinical study investigating the role of lymphadenectomy, surgical
castration and adjuvant hormonal treatment in endometrial stromal
sarcoma. Br J Cancer. 97:1194–1199. 2007.PubMed/NCBI View Article : Google Scholar
|
14
|
Berchuck A, Rubin SC, Hoskins WJ, Saigo
PE, Pierce VK and Lewis JL Jr: Treatment of endometrial stromal
tumors. Gynecol Oncol. 36:60–65. 1990.PubMed/NCBI View Article : Google Scholar
|
15
|
Li N, Wu LY, Zhang HT, An JS, Li XG and Ma
SK: Treatment options in stage I endometrial stromal sarcoma: A
retrospective analysis of 53 cases. Gynecol Oncol. 108:306–311.
2008.PubMed/NCBI View Article : Google Scholar
|
16
|
Shah JP, Bryant CS, Kumar S, Ali-Fehmi R,
Malone JM Jr and Morris RT: Lymphadenectomy and ovarian
preservation in low-grade endometrial stromal sarcoma. Obstet
Gynecol. 112:1102–1108. 2008.PubMed/NCBI View Article : Google Scholar
|
17
|
Reich O and Regauer S: Aromatase
expression in low-grade endometrial stromal sarcomas: An
immunohistochemical study. Mod Pathol. 17:104–108. 2004.PubMed/NCBI View Article : Google Scholar
|
18
|
Ushijima K, Yahata H, Yoshikawa H, Konishi
I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, et
al: Multicenter phase II study of fertility-sparing treatment with
medroxyprogesterone acetate for endometrial carcinoma and atypical
hyperplasia in young women. J Clin Oncol. 25:2798–1803.
2007.PubMed/NCBI View Article : Google Scholar
|